nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases
|
Vogl, Thomas Josef |
|
2009 |
58 |
10 |
p. 1557-1563 |
artikel |
2 |
Anti-cancer activity and mechanistic features of a NK cell activating molecule
|
Kim, Hyung-Ran |
|
2009 |
58 |
10 |
p. 1691-1700 |
artikel |
3 |
A systematic review of humoral immune responses against tumor antigens
|
Reuschenbach, Miriam |
|
2009 |
58 |
10 |
p. 1535-1544 |
artikel |
4 |
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
|
Gedye, Craig |
|
2009 |
58 |
10 |
p. 1635-1646 |
artikel |
5 |
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response
|
Delluc, Stéphanie |
|
2009 |
58 |
10 |
p. 1669-1677 |
artikel |
6 |
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
|
Britten, Cedrik Michael |
|
2009 |
58 |
10 |
p. 1701-1713 |
artikel |
7 |
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of cultures
|
Ingram, Wendy |
|
2009 |
58 |
10 |
p. 1679-1690 |
artikel |
8 |
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)
|
Elkord, Eyad |
|
2009 |
58 |
10 |
p. 1657-1667 |
artikel |
9 |
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)
|
Elkord, Eyad |
|
|
58 |
10 |
p. 1657-1667 |
artikel |
10 |
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2
|
Le, Hanh K. |
|
2009 |
58 |
10 |
p. 1565-1576 |
artikel |
11 |
Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity
|
Abdel-Motal, Ussama M. |
|
2009 |
58 |
10 |
p. 1545-1556 |
artikel |
12 |
Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses
|
Zhou, Jun |
|
2009 |
58 |
10 |
p. 1587-1597 |
artikel |
13 |
Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro
|
Liu, Wujiang |
|
2009 |
58 |
10 |
p. 1647-1655 |
artikel |
14 |
Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
|
Nagai, Taku |
|
2009 |
58 |
10 |
p. 1577-1586 |
artikel |
15 |
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma
|
Helgadottir, Hildur |
|
2009 |
58 |
10 |
p. 1599-1608 |
artikel |
16 |
Treatment of non-Hodgkin’s lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy
|
O’Donnell, Robert T. |
|
2009 |
58 |
10 |
p. 1715-1722 |
artikel |
17 |
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
|
Banissi, Claire |
|
2009 |
58 |
10 |
p. 1627-1634 |
artikel |
18 |
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
|
Kyte, Jon Amund |
|
2009 |
58 |
10 |
p. 1609-1626 |
artikel |